Abstract Library

Welcome to the open-access search for all ENETS abstracts presented at the Annual ENETS Conferences.

Everyone can browse the library to find basic information on abstracts. To get full access to each entry, you will be asked to log in to your myENETS account.

 

Please note:

Participants of the 2025 ENETS Conference enjoy full access to the 2025 conference digital resources through myENETS: the abstract booklet, e-posters and videos, slide decks of talks, the poster carousel, and more.

Log in to myENETS

ENETS Abstract Search

#4553 The efficacy of “rechallenge” peptide receptor radionuclide therapy (PRRT) may be inferior to that of the initial PRRT, while the safety profile remains comparable

Introduction: Data on efficacy and adverse events of re-challenge PRRT (re-PRRT) for patients with gastrointestinal neuroendocrine tumours (GI-NETs) are limited.

Conference:

Presenting Author: Heinrich M

Authors: Heinrich M, Lutz F, Alwers S, Däubler C, Buck A,

Keywords: gastrointestinal neuroendocrine tumour, somatostatin receptor directed PET, laboratory parameters, Progression-free survival,

#3749 Elevated inflammatory markers are associated with poor survival after surgery for pancreatic and small intestine neuroendocrine tumors

Introduction: Gastroenteropancreatic neuroendocrine tumors (GEP-NET) are a heterogenous group of neoplasms. The only curative treatment is surgery. However, predictors of survival after surgery are still missing.

Conference:

Presenting Author:

Authors: Amin T, Kailani S, Fründt T, Viol F, Stripling J,

Keywords: Neuroendocrine tumor, inflammatory marker, GEP-NET, overall survival,

#3660 Prognostic value of inflammation-related biomarkers in patients with gastroenteropancreatic neuroendocrine neoplasms (GEP-NENs) – A systematic review and meta-analysis

Introduction: Hematological indicators of chronic systemic inflammation are among the most promising biomarkers for GEP-NENs, but their prognostic value remains controversial.

Conference:

Presenting Author: Yu F

Authors: Yu F, Cheng Z, Su F, Chen Y, Tan H,

Keywords: Gastroenteropancreatic neuroendocrine neoplasm, inflammation-related biomarker, prognostic value,

#3292 Neuroendocrine differentiation of metastasised castrate-resistant prostate cancer patients referred for radioligand therapy with Lu-177 PSMA

Introduction: Neuroendocrine differentiation (NED) of metastasised castrate-resistant prostate cancer (mCRPC) is normally associated with poor prognosis.

Conference: 18th Annual ENETS Concerence (2021)

Presenting Author: Prasad V

Authors: Grunert M, Miksch J, Steinacker J, Zengerling F, Glatting G,

Keywords: NED, mCRPC, CgA, NSE, RLT, overall survival,

#2958 The Blood-based Multigenomic NETest Accurately Identifies Neuroendocrine Transformed Prostate Cancer

Introduction: Neuroendocrine differentiation and an aggressive phenotype is an important feature of castration-resistant prostate cancer (CRPC). Current biomarkers are unable to detect these advanced, treatment refractory variants.

Conference: 17th Annual ENETSConcerence (2020)

Presenting Author: Modlin I

Authors: Modlin I, Kidd M, Rahbar K, Malczewska A, Rajwa P,

Keywords: Biomarker, NETest, PSA, prostate cancer, neuroendocrine phenotype, castration-resistance, neuroendocrine,